Public filings / CRVS on Yahoo Finance (opens in a new tab)
CRVS: insider buying, 13F holders, analyst moves
Corvus Pharmaceuticals Inc - US
A summary of public filings about Corvus Pharmaceuticals Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold CRVS
Combined reported value $84.1M.
Holders among our 100 managers: 1 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Perceptive Advisors | $39.9M | 0.62% | Added |
| Deep Track Capital | $37.2M | 0.55% | Unchanged |
| RA Capital | $6.7M | 0.06% | Unchanged |
| Tudor Investment | $329K | 0.00% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.